|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0030705,
umls-concept:C0036525,
umls-concept:C0087111,
umls-concept:C0205145,
umls-concept:C0205179,
umls-concept:C0205225,
umls-concept:C0242957,
umls-concept:C0332293,
umls-concept:C0449438,
umls-concept:C1522484
|
|
pubmed:issue |
1B
|
|
pubmed:dateCreated |
2006-6-2
|
|
pubmed:abstractText |
The aim of this prospective study was to investigate whether there were changes in HER-2/neu status in newly-developed metastatic lesions following treatment with trastuzumab in advanced breast cancer patients overexpressing HER-2/neu. The utility of serological assays for HER-2/neu in such patients was also studied.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
647-53
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16739334-Antibodies, Monoclonal,
pubmed-meshheading:16739334-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:16739334-Antineoplastic Agents,
pubmed-meshheading:16739334-Breast Neoplasms,
pubmed-meshheading:16739334-Female,
pubmed-meshheading:16739334-Humans,
pubmed-meshheading:16739334-Immunohistochemistry,
pubmed-meshheading:16739334-Neoplasm Metastasis,
pubmed-meshheading:16739334-Prospective Studies,
pubmed-meshheading:16739334-Receptor, erbB-2
|
|
pubmed:articleTitle |
HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy.
|
|
pubmed:affiliation |
Second Department of Internal Medicine-Propaedeutic, Oncology Section, Attikon University Hospital, Athens, Greece. pectasid@otenet.gr
|
|
pubmed:publicationType |
Journal Article
|
